FASLG and systemic lupus erythematosus: The soon-to-be updated EULAR recommendations regarding the management of SLE-associated APS do not, in these aspects, differ from the 2019 guidelines that state that low-dose acetylsalicylic acid can be prescribed in asymptomatic patients with a high-risk aPL profile (30).